Law, Culture and Reprisals: A Qualitative Case Study of Whistleblowing & Health Canada's Drug Approval Process

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat or click here to download the PDF file.

Click here to download the PDF file.


Forward, Pamela M.




Abstract Countries around the world consider whistleblowing a first and often best early warning system for corruption and regulatory failure because whistleblowers are usually organizational insiders with first-hand knowledge of complex systems often impenetrable and unintelligible to outsiders. Why then do whistleblowers, these harbingers of wrongdoing, suffer censure and reprisals? The answer to this question sparked this case study of a whistleblower’s concerns regarding the effectiveness of Health Canada’s drug approval process in 1996 and the resulting impact on the whistleblower, the organization and ultimately the implications for public safety and accountable government. The methods used were process-tracing, in-depth interviews and data and document review. The results suggested problems with culture in the main organization Health Canada, possibly exacerbated by deregulation. The conclusion is a multi-faceted approach to addressing culture is needed before whistleblower protection legislation can work and accountable organizations can flourish.


Psychology - Behavioral




Carleton University

Thesis Degree Name: 

Master of Arts: 

Thesis Degree Level: 


Thesis Degree Discipline: 

Legal Studies

Parent Collection: 

Theses and Dissertations

Items in CURVE are protected by copyright, with all rights reserved, unless otherwise indicated. They are made available with permission from the author(s).